Pharmaceutical standardization and comparative clinical efficacy of Abhraka Bhasma (with and without Amrutikarana) in the management of Type 2 Diabetes (Madhumeha)

Institute for Post Graduate Teaching and Research in Ayurveda0 个研究点目标入组 101 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Either the sexes having age between 18 to 60 years.
•Patients having chief & associated complains of Madhumeha (Prabhuta-Avilamutrata, pipashadhikya, kshudhadhikya etc.)
•Patients with stable continuous dose of modern medicine for more than 1 month.
•Known patient of Type 2 Diabetes and also the preliminarily diagnosed patients on the basis of signs and symptoms of the disease are confirmed by FBS and PPBS.

•Age more than 60 and below18 years
•Prameha pidika (Diabetic nonhealing wound), Systemic infection, active infection other than superficial mild skin infestation
•Secondary Diabetes mellitus and Diabetes mellitus Type 1
•Patients of any other severe illness.
•Malignant and accelerated hypertensive.
•Other chronic debilitating diseases.
•Pregnant woman and expecting conception (within six month)
•Lactating mothers.
•Patients with fatal diabetic complication like end stage renal disease
•Patient with diabetic ketoacidosis
•Severe anaemia below 7gm% Hb.

发起方

Institute for Post Graduate Teaching and Research in Ayurveda